Antonia Kolokathi, M.D.

Dr. Antonia Ann Kolokathis obtained her Medical Degree from the National University of Athens. She completed her residency and fellowship in Internal Medicine and Infectious Diseases at the Icahn School of Medicine at Mount Sinai and Beth Israel Medical Center. After completing her clinical fellowship, she was funded by the Rockefeller Foundation for research on antibiotic resistance mechanisms, and became faculty at the Mount Sinai School of Medicine studying HIV and Tuberculosis.

Dr. Kolokathis started her pharmaceutical career at Pfizer Inc. as Vice President responsible for Anti-Infective, Immunology, Pain, Arthritis and Women's Health programs. She later joined Bristol Myers Squibb for Virology programs, served as Senior Vice President at Vertex Pharmaceuticals, and as Chief Medical Officer at Optimer Pharmaceuticals.

She has been a member of the Institute of Medicine (IOM) forum on Drug Discovery and served on the United States PEPFAR initiative. In 2005, she was assigned by the WHO as Senior Consultant for Tsunami Relief and Recovery in Southeast Asia. Dr. Kolokathis currently consults for Biopharmaceutical companies and public and private organizations.

Together with Dr. George Liakeas she produces the medical program ΥΓΕΙΑ ΤΟΥ ΚΟΣΜΟΥ [Health of the World] once every month during the Saturday lineup.